Suppr超能文献

甲基多巴与拉贝洛尔治疗高血压的对比研究。

A comparative study of methyldopa and labetalol in the treatment of hypertension.

作者信息

Sanders G L, Davies D M, Gales G M, Rao J G, Rawlins M D, Routledge P A

出版信息

Br J Clin Pharmacol. 1979;8(Suppl 2):149S-151S.

Abstract

1 Twenty patients with essential hypertension completed a double-blind, dose-tritrated, cross-over comparison of methyldopa and labetalol. 2 Average lying BPs (systolic/diastolic) were reduced by 28/15 mmHg with methyldopa and by 23/15 mmHg with labetalol. 3 Average standing BPs (systolic/diastolic) were reduced by 29/14 mmHg with methyldopa and by 29/15 mmHg with labetalol. 4 Both lying and standing heart rates were reduced with labetalol. 5 It is concluded that the antihypertensive properties of labetalol and methyldopa are similar but that larger patient populations are needed to study the relative incidence of subjective adverse effects.

摘要
  1. 二十名原发性高血压患者完成了甲基多巴和拉贝洛尔的双盲、剂量滴定、交叉对照比较。2. 甲基多巴使平均卧位血压(收缩压/舒张压)降低28/15 mmHg,拉贝洛尔使其降低23/15 mmHg。3. 甲基多巴使平均立位血压(收缩压/舒张压)降低29/14 mmHg,拉贝洛尔使其降低29/15 mmHg。4. 拉贝洛尔使卧位和立位心率均降低。5. 得出的结论是,拉贝洛尔和甲基多巴的降压特性相似,但需要更大规模的患者群体来研究主观不良反应的相对发生率。

相似文献

2
A comparative study of methyldopa and labetalol in the treatment of hypertension.
Br J Clin Pharmacol. 1979 Apr;8 Suppl 2:149S-51S. doi: 10.1111/j.1365-2125.1979.tb04771.x.
4
Labetalol, a cross-over double blind controlled trial.
Eur J Clin Pharmacol. 1978 Dec 18;14(5):301-4. doi: 10.1007/BF00611897.
9
Double-blind trial of labetalol.拉贝洛尔双盲试验。
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):737-41.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验